Nutritional Neuropathy Workup

  • Author: R Andrew Sewell, MD; Chief Editor: Nicholas Lorenzo, MD   more...
 
Updated: Sep 27, 2010
 

Laboratory Studies

  • The neuropathy first must be characterized as a polyneuropathy, mononeuropathy, mononeuropathy multiplex disease, or plexopathy; motor, sensory, sensorimotor, motor-sensory, or autonomic; acute or chronic; and of demyelinating or axonal pathophysiology. Readily apparent clues in the history can often suggest that the peripheral neuropathy might be secondary to nutritional problems; they are as follows:
    • Excessive consumption of alcohol
    • History of bariatric surgery, especially gastrectomy and intestinal shortening
    • History of GI syndromes indicating a predisposition toward malabsorption
    • History of using medications known to be associated with a vitamin deficiency (e.g., isoniazid)
  • Once the neuropathy is suspected to be nutritional in origin, the physician should first assess a possible vitamin B 12 deficiency (remembering that a CBC is not a good indicator). Documenting other B vitamin deficiencies is not as important because treatment replaces these vitamins anyway.
  • If history—which is the key to diagnosing a nutritional neuropathy—and physical are unrevealing, check CBC, urinalysis, thyroid-stimulating hormone (TSH), glucose, renal and hepatic functions, vitamin B 12 level, erythrocyte sedimentation rate (ESR), and serum protein electrophoresis, then order other tests, such as copper, as needed. Electrophysiologic findings can confirm the impression of polyneuropathy but rarely provide the diagnosis.
    • Alcohol neuropathy: CBC may show low platelet counts and a megaloblastic anemia due to decreased folate levels.
    • Thiamine (vitamin B 1 ) deficiency: A serum thiamine (vitamin B 1 ) level is not a good index because it responds quickly to dietary supplementation and because it is a poor indicator of total body stores. Urinary excretion of < 65 mg/g of creatinine is abnormal. A pyruvate level of >1 mg/dL is a reliable indicator of deficiency. The best test is erythrocyte transketolase activity; a concentration of < 0.017 U/dL indicates deficiency.
    • Pyridoxine (vitamin B 6 ) deficiency: The CBC shows a microcytic, hypochromic anemia with normal iron levels. Serum pyridoxine levels are < 25 mg/mL, and serum homocysteine and cysathioprine values should be elevated. A tryptophan-loading test (not commonly performed) reveals urinary xanthurenic acid excretion of >50 mg/d.
    • Folate deficiency: Serum folate levels are low.
    • Niacin (vitamin B 3 ) deficiency: Urinary excretion of N -methylnicotinamide + N -methyl-6-pyridone-3-carboxamide is < 2 mg, or urinary excretion of N -methylnicotinamide is < 0.5 mg/g creatinine. Performing a stress test is possible by giving niacin 10 mg and tryptophan 100 mg. If urinary excretion of niacin metabolites is < 3 mg, a deficiency is present.
    • Cyanocobalamin (vitamin B 12 ) deficiency: The CBC may show mean corpuscular volume (MCV) >110 fL (ie, macrocytic anemia), anisocytosis, poikilocytosis, and large and oval erythrocytes with decreased reticulocyte, leukocyte, and platelet counts. However, the neuropathy may precede any hematologic abnormalities in 25% of patients. The serum cobalamin level is < 10 mg/dL but may be normal, even in those with a tissue cobalamin deficit. Serum homocysteine and methylmalonic acid levels are elevated, as is urinary methylmalonic acid excretion. Serum holotranscobalamin II is deficient. Intrinsic factor antibodies are specific for pernicious anemia but not very sensitive (40% negative). The traditional Schilling test is now rarely used.
    • Pantothenic acid deficiency: Excretion is < 1 mg/d.
    • Alpha-tocopherol (vitamin E) deficiency: The serum α -tocopherol (vitamin E) level is low, and the CBC shows acanthocytes. Normal serum α -tocopherol levels in an adult with symptoms consistent with Friedreich ataxia should prompt an investigation for an autosomal recessive defect in the tocopherol transporter protein gene on chromosome 8.
    • Hypophosphatemia: Serum phosphate level is < 1 mg/dL.
    • Gluten-sensitive neuropathy: Anti-gliadin antibodies, either IgM or IgA should be present. 90% have HLA DQ2. Intestinal biopsy is abnormal in only 35%.
Next

Imaging Studies

  • Imaging studies are generally not useful. In thiamine deficiency, MRIs occasionally show abnormal signal intensity in periaqueductal gray matter and midline structures.
  • Radiographs of chronic peripheral neuropathies are often consistent with the picture of a diabetic foot.
Previous
Next

Other Tests

  • Axonal loss manifests as a mild slowing of the nerve conduction velocity (NCV) with a disproportionate loss of amplitude. Demyelination, on the other hand, produces mild loss of amplitude with a disproportionate slowing of the NCV. In affected motor fibers, electromyography (EMG) shows fibrillations, positive sharp waves, and decreased motor unit potentials. EMG and NCV are useful to assess the degree of damage and monitor progression of the neuropathy.
    • Thiamine (vitamin B 1 ) deficiency: EMG and nerve conduction studies reveal a generalized axonal sensorimotor polyneuropathy with denervation of the distal lower extremity musculature; at times some subtle demyelinating features may be present.
    • Niacin (vitamin B 3 ): EMG and NCV show demyelination in mild cases and axonal degeneration in severe cases.
    • Alpha-tocopherol (vitamin E) deficiency: Peripheral nerve conduction findings are normal. Sensory evoked potentials are low or absent. Somatosensory evoked potentials show a delay in central conduction. EMG findings are normal.
  • Sensorineural hearing loss: Audiometry shows high-tone hearing loss.
  • Alcohol: The CSF protein level on lumbar puncture is normal or slightly elevated.
Previous
Next

Histologic Findings

A biopsy is not indicated unless the diagnosis is in doubt. If so, biopsy is indicated only if the neuropathy is multifocal or asymmetric, or if the patient has multiple mononeuropathies. The best nerve to biopsy is the sural nerve, lateral to the lateral malleolus. In general, sural nerve biopsy is of limited use in differentiating various types of nutritional neuropathy, but it can help in distinguishing hereditary neuropathy, neuropathy caused by organic solvents, leprosy, amyloidosis, polyarteritis nodosa, or sarcoidosis, and it is occasionally useful in evaluating Guillain-Barré syndrome. Nutritional neuropathies can result in either demyelinating or axonal peripheral nerve pathology.

Previous
 
 
Contributor Information and Disclosures
Author

R Andrew Sewell, MD  Associate Research Scientist in Psychiatry and Mental Illness Research, Education,Veterans Affairs Connecticut Health Care System, Yale University School of Medicine

R Andrew Sewell, MD is a member of the following medical societies: American Academy of Neurology, American Headache Society, American Pain Society, and American Psychiatric Association

Disclosure: Nothing to disclose.

Coauthor(s)

Lawrence D Recht, MD  Professor of Neurology and Neurosurgery, Department of Neurology and Clinical Neurosciences, Stanford University Medical School

Lawrence D Recht, MD is a member of the following medical societies: American Academy of Neurology, American Association for Cancer Research, American Neurological Association, and Society for Neuroscience

Disclosure: Nothing to disclose.

Specialty Editor Board

Milind J Kothari, DO  Professor and Vice-Chair, Department of Neurology, Pennsylvania State University College of Medicine; Consulting Staff, Department of Neurology, Penn State Milton S Hershey Medical Center

Milind J Kothari, DO is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Neurological Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Glenn Lopate, MD  Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University School of Medicine; Director of Neurology Clinic, St Louis ConnectCare; Consulting Staff, Department of Neurology, Barnes-Jewish Hospital

Glenn Lopate, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and Phi Beta Kappa

Disclosure: Baxter Grant/research funds Other; Amgen Grant/research funds None

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

Chief Editor

Nicholas Lorenzo, MD  Consulting Staff, Neurology Specialists and Consultants

Nicholas Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, and American College of Physician Executives

Disclosure: Nothing to disclose.

References
  1. Poitou Bernert C, Ciangura C, Coupaye M, Czernichow S, Bouillot JL, Basdevant A. Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment. Diabetes Metab. Feb 2007;33(1):13-24. [Medline].

  2. Prodan CI, Bottomley SS, Vincent AS, Cowan LD, Greenwood-Van Meerveld B, Holland NR. Copper deficiency after gastric surgery: a reason for caution. Am J Med Sci. Apr 2009;337(4):256-8. [Medline].

  3. Menezes MS, Harada KO, Alvarez G. Painful peripheral polyneuropathy after bariatric surgery. Case reports. Rev Bras Anestesiol. May-Jun 2008;58(3):252-9. [Medline].

  4. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJ. A controlled study of peripheral neuropathy after bariatric surgery. Neurology. Oct 26 2004;63(8):1462-70. [Medline].

  5. Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grünewald RA, Davies-Jones AG. Sensory ganglionopathy due to gluten sensitivity. Neurology. Sep 14 2010;75(11):1003-8. [Medline].

  6. Gill GV, Bell DR. Persisting nutritional neuropathy amongst former war prisoners. J Neurol Neurosurg Psychiatry. Oct 1982;45(10):861-5. [Medline].

  7. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJ. A controlled study of peripheral neuropathy after bariatric surgery. Neurology. Oct 26 2004;63(8):1462-70. [Medline].

  8. Kesler A, Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep. Sep 2003;3(5):410-4. [Medline].

  9. Tanyel MC, Mancano LD. Neurologic findings in vitamin E deficiency. Am Fam Physician. Jan 1997;55(1):197-201. [Medline].

  10. Tanyel MC, Mancano LD. Neurologic findings in vitamin E deficiency. Am Fam Physician. Jan 1997;55(1):197-201. [Medline].

  11. Kesler A, Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep. Sep 2003;3(5):410-4. [Medline].

  12. Chang CG, Adams-Huet B, Provost DA. Acute post-gastric reduction surgery (APGARS) neuropathy. Obes Surg. Feb 2004;14(2):182-9. [Medline].

  13. Diamond I, Messing RO. Neurologic effects of alcoholism. West J Med. Sep 1994;161(3):279-87. [Medline].

  14. Erbsloh F, Abel M. Deficiency neuropathies. In: Bruyn GW, Vinken PJ, eds. Handbook of Clinical Neurology. Vol 7: Diseases of Nerves, Part I. New York: Wiley Interscience Division; 1970:558-638.

  15. Forbes CD, Jackson WF. A Colour Atlas and Text of Clinical Medicine. 1993. Aylesbury: Hazell Books Ltd; 428.

  16. Gill GV, Bell DR. Persisting nutritional neuropathy amongst former war prisoners. J Neurol Neurosurg Psychiatry. Oct 1982;45(10):861-5. [Medline].

  17. Hattori N, Koike H, Sobue G. [Metabolic and nutritional neuropathy]. Rinsho Shinkeigaku. Nov 2008;48(11):1026-7. [Medline].

  18. Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol. Oct 2006;19(5):481-6. [Medline].

  19. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc. Oct 2006;81(10):1371-84. [Medline].

  20. Le Quesne PM. Persisting nutritional neuropathy in former war prisoners. Br Med J (Clin Res Ed). Mar 19 1983;286(6369):917-8. [Medline].

  21. Li K, McKay G. Images in clinical medicine. Ischemic retinopathy caused by severe megaloblastic anemia. N Engl J Med. Mar 23 2000;342(12):860. [Medline].

  22. Pallis CA. Neurological manifestations of nutritional disorders. Practitioner. Apr 1974;212(1270 Spec No):509-17. [Medline].

  23. Theodoropoulos DS. Optic neuropathy in vitamin B12 deficiency [letter; comment]. Lancet. Jul 11 1998;352(9122):146-7. [Medline].

  24. Weber GA, Sloan P, Davies D. Nutritionally-induced peripheral neuropathies. Clin Podiatr Med Surg. Jan 1990;7(1):107-28. [Medline].

Previous
Next
 
Pernicious anemia. Characteristic lemon-yellow–tinged pallor with raw-beef tongue lacking filiform papillae. Used with permission from Forbes and Jackson.
Ischemic retinopathy caused by severe megaloblastic anemia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.